We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$892M
AUM Growth
+$114M
Cap. Flow
+$142M
Cap. Flow %
15.87%
Top 10 Hldgs %
24.46%
Holding
5,559
New
1,359
Increased
1,658
Reduced
1,483
Closed
897

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$23.8M
2
AAPL icon
Apple
AAPL
+$21.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$11.6M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$11.5M
5
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$10.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$9.03M
3
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$8.9M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$7.17M
5
UYG icon
ProShares Ultra Financials
UYG
+$6.09M

Sector Composition

Rank Sector Weight
1 Technology 9.8%
2 Healthcare 7.16%
3 Financials 6.42%
4 Consumer Discretionary 4.97%
5 Communication Services 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
2126
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$25K ﹤0.01%
+1,966
New +$24.4K
PCI
2127
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
$25K ﹤0.01%
1,112
-3,088
-74% -$71.2K
SHLO
2128
DELISTED
Shiloh Industries Inc
SHLO
$25K ﹤0.01%
1,489
-213
-13% -$3.72K
ECYT
2129
DELISTED
Endocyte, Inc. Common Stock
ECYT
$25K ﹤0.01%
4,103
+3,653
+812% +$24.9K
XOXO
2130
DELISTED
Xo Group Inc
XOXO
$25K ﹤0.01%
2,223
+871
+64% +$10.3K
MSCC
2131
DELISTED
Microsemi Corp
MSCC
$25K ﹤0.01%
+965
New +$24.7K
BEAV
2132
DELISTED
B/E Aerospace Inc
BEAV
$25K ﹤0.01%
409
-13,250
-97% -$838K
CSI
2133
DELISTED
Cutwater Select Income Fund
CSI
$25K ﹤0.01%
1,243
-1,366
-52% -$26.8K
PSG
2134
DELISTED
Performance Sports Group Ltd.
PSG
$25K ﹤0.01%
+1,538
New +$25.8K
GTU
2135
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
$25K ﹤0.01%
600
+131
+28% +$5.89K
ANR
2136
DELISTED
Alpha Natural Resources Inc
ANR
$25K ﹤0.01%
9,975
+6,282
+170% +$21.7K
VIAS
2137
DELISTED
VIASYSTEMS GROUP INC COM STK (DE)
VIAS
$25K ﹤0.01%
1,552
+717
+86% +$8.09K
IRF
2138
DELISTED
INTL RECTIFIER CORP
IRF
$25K ﹤0.01%
628
-3,369
-84% -$109K
AMZG
2139
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
$25K ﹤0.01%
6,150
+5,278
+605% +$29.1K
ORBC
2140
DELISTED
ORBCOMM, Inc.
ORBC
$25K ﹤0.01%
+4,386
New +$27.4K
NMRX
2141
DELISTED
Numerex Corp
NMRX
$25K ﹤0.01%
2,335
-2,346
-50% -$25.6K
DNY
2142
DELISTED
DONNELLEY R R & SONS CO
DNY
$25K ﹤0.01%
1,500
-7,884
-84% -$131K
BBSI icon
2143
Barrett Business Services
BBSI
$804M
$24K ﹤0.01%
2,472
+1,900
+332% +$25.8K
CEVA icon
2144
CEVA Inc
CEVA
$1.08B
$24K ﹤0.01%
1,758
+1,527
+661% +$22.4K
ETD icon
2145
Ethan Allen Interiors
ETD
$603M
$24K ﹤0.01%
1,050
-48
-4% -$1.16K
FBP icon
2146
First Bancorp
FBP
$4.38B
$24K ﹤0.01%
5,100
-12,075
-70% -$62.3K
FOLD
2147
DELISTED
Amicus Therapeutics
FOLD
$24K ﹤0.01%
4,000
+1,693
+73% +$8.87K
IRMD icon
2148
iRadimed
IRMD
$1.18B
$24K ﹤0.01%
+3,425
New +$31K
JJSF icon
2149
J&J Snack Foods
JJSF
$1.71B
$24K ﹤0.01%
256
-187
-42% -$17.6K
LCTX icon
2150
Lineage Cell Therapeutics
LCTX
$278M
$24K ﹤0.01%
9,552
+7,257
+316% +$17.5K
84 85
86
87 88

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2014 Portfolio in Review

As of Q3 2014, Tower Research Capital (TRC) held 5,559 positions worth $892M, up 15% from $778M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $142M of net new capital in Q3 2014, opening 1,359 new positions and adding to 1,658 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 5.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $106M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2014 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q3 2014, an estimated $23.8M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $106M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Value ETF in Q3 2014, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $892M portfolio in Q3 2014.
  • Tower Research Capital (TRC) opened 1,359 new positions and closed 897 in Q3 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 15% quarter-over-quarter to $892M.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2014, filed 31 Oct 2014.